ACI's 8th Annual Summit on Life Sciences IP Due Diligence

Loeb & Loeb LLP is proud to sponsor the ACI's 8th Annual Summit on Life Sciences IP Due Diligence taking place from December 3-4, 2025, where Co-Chair, Life Sciences, Kathleen Gersh will be speaking on the panel “How the Loss of Chevron Deference Upped the Ante for Patent Risk: The Impact of Agency Rule Challenges Under Loper Bright on Diligence Reviews” on December 3.

From the event website:
This December, ACI returns to Boston for our 8th Annual Summit on Life Sciences IP Due Diligence, bringing you the latest insights to keep your due diligence rigorous and effective, without breaking the bank.

For more information, including how to register, please visit the event website.